Glaukos Corporation (GKOS)
NYSE: GKOS · IEX Real-Time Price · USD
118.98
+1.56 (1.33%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Glaukos Market Cap
Glaukos has a market cap or net worth of $5.99 billion as of July 2, 2024. Its market cap has increased by 84.24% in one year.
Market Cap
5.99B
Enterprise Value
6.10B
1-Year Change
84.24%
Ranking
Category
Stock Price
$118.98
Market Cap Chart
Since June 25, 2015, Glaukos's market cap has increased from $999.60M to $5.99B, an increase of 499.51%. That is a compound annual growth rate of 21.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 5.91B | 52.46% |
| Dec 29, 2023 | 3.88B | 86.16% |
| Dec 30, 2022 | 2.08B | -0.00% |
| Dec 31, 2021 | 2.08B | -38.42% |
| Dec 31, 2020 | 3.38B | 68.22% |
| Dec 31, 2019 | 2.01B | -0.60% |
| Dec 31, 2018 | 2.02B | 128.25% |
| Dec 29, 2017 | 886.60M | -22.95% |
| Dec 30, 2016 | 1.15B | 45.18% |
| Dec 31, 2015 | 792.60M | -20.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exelixis | 6.55B |
| Revolution Medicines | 6.40B |
| Acadia Healthcare Company | 6.27B |
| Cytokinetics | 6.21B |
| Madrigal Pharmaceuticals | 5.97B |
| Viking Therapeutics | 5.85B |
| Tempus AI | 5.78B |
| Lantheus Holdings | 5.57B |